Molecular Imaging for Neuroendocrine Tumors: Somatostatin Receptor-Based Diagnostics
Systematic review of molecular imaging in neuroendocrine tumor diagnosis covers somatostatin receptor-based PET/CT and SPECT, guiding diagnostic and treatment selection decisions.
Quick Facts
What This Study Found
Systematic review of molecular imaging in neuroendocrine tumor diagnosis covers somatostatin receptor-based PET/CT and SPECT, guiding diagnostic and treatment selection decisions.
Key Numbers
Systematic review examining diagnostic accuracy of multiple molecular imaging modalities for CUP-NETs.
How They Did This
Methodology in publication.
Why This Research Matters
Relevant to peptide-based therapeutic applications.
The Bigger Picture
Contributes to peptide therapeutic evidence.
What This Study Doesn't Tell Us
Limitations in publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to evidence?
- ?Next research?
Trust & Context
- Key Stat:
- Key finding Systematic review of molecular imaging in neuroendocrine tumor diagnosis covers somatostatin recepto
- Evidence Grade:
- Based on study design.
- Study Age:
- Published in 2025.
- Original Title:
- Molecular imaging in the diagnostic process of neuroendocrine tumors: a systematic review on unknown primary origin and suspected NETs.
- Published In:
- EJNMMI reports, 9(1), 38 (2025)
- Authors:
- Alonzo, Laura, Cannella, Roberto, Laudicella, Riccardo, Benfante, Viviana, Purpura, Pierpaolo, Micci, Giuseppe, Galia, Massimo, Brancatelli, Giuseppe, Midiri, Massimo, Alongi, Pierpaolo
- Database ID:
- RPEP-09895
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Systematic review of molecular imaging in neuroendocrine tumor diagnosis covers somatostatin receptor-based PET/CT and SPECT, guiding diagnostic and treatment selection decisions.
How reliable?
Consult publication and provider.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09895APA
Alonzo, Laura; Cannella, Roberto; Laudicella, Riccardo; Benfante, Viviana; Purpura, Pierpaolo; Micci, Giuseppe; Galia, Massimo; Brancatelli, Giuseppe; Midiri, Massimo; Alongi, Pierpaolo. (2025). Molecular imaging in the diagnostic process of neuroendocrine tumors: a systematic review on unknown primary origin and suspected NETs.. EJNMMI reports, 9(1), 38. https://doi.org/10.1186/s41824-025-00274-4
MLA
Alonzo, Laura, et al. "Molecular imaging in the diagnostic process of neuroendocrine tumors: a systematic review on unknown primary origin and suspected NETs.." EJNMMI reports, 2025. https://doi.org/10.1186/s41824-025-00274-4
RethinkPeptides
RethinkPeptides Research Database. "Molecular imaging in the diagnostic process of neuroendocrin..." RPEP-09895. Retrieved from https://rethinkpeptides.com/research/alonzo-2025-molecular-imaging-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.